— Know what they know.
Not Investment Advice
Also trades as: COH.AX (ASX) · $vol 53M · CHEOY (OTC) · $vol 3M

CHEOF OTC

Cochlear Limited
1W: +0.0% 1M: -1.4% 3M: +15.0% YTD: -44.5% 1Y: -47.4% 3Y: -41.2% 5Y: -42.1%
$93.61
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Devices · Tech Score Sell · Power 44 · $6.1B mcap · 65M float · 0.0018% daily turnover · Short 92% of daily vol

Income Trends

Revenue
$2.3B -0.5% ▼
5Y CAGR: +9.3%
Gross Profit
$1.6B -4.8% ▼
5Y CAGR: +8.6%
Operating Income
$301M -26.0% ▼
5Y CAGR: -4.1%
Net Income
$147M -62.2% ▼
5Y CAGR: -14.7%
EPS (Diluted)
$2.24 -62.2% ▼
5Y CAGR: -14.6%
EBITDA
$406M -34.4% ▼
5Y CAGR: -2.3%

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2022FY2023FY2024FY2025FY2026
Revenue$1.6B$1.9B$2.2B$2.3B$2.3B
YoY Growth+10.1%+17.5%+15.5%+4.8%-0.5%
Cost of Revenue$411M$488M$562M$615M$687M
Gross Profit$1.2B$1.4B$1.7B$1.7B$1.6B
Gross Margin75.1%74.8%74.9%73.7%70.5%
R&D Expenses$211M$245M$277M$292M$323M
SG&A Expenses$658M$810M$898M$940M$1.0B
Operating Expenses$941M$1.1B$1.3B$1.3B$1.3B
Operating Income$402M$390M$475M$406M$301M
Operating Margin24.4%20.1%21.2%17.3%12.9%
Interest Expense$9M$9M$9M$11M$13M
Income Before Tax$394M$397M$485M$518M$201M
Tax Expense$105M$96M$128M$130M$54M
Net Income$289M$301M$357M$389M$147M
Net Margin17.5%15.5%16.0%16.6%6.3%
EPS (Diluted)$4.40$4.56$5.43$5.93$2.24
EBITDA$475M$487M$579M$620M$406M
Shares Outstanding66M66M66M66M66M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms